Insured women were 15 times more likely to initiate hepatitis treatment

Women who reported having health insurance were significantly more likely to initiate hepatitis C treatment vs. women without health insurance, according to a study published in Clinical Infectious Diseases.
“Direct-acting antivirals (DAAs) are highly effective at curing hepatitis C and recommended for most people. However, the high cost of these newer medications is a major barrier to access,” Andrew Edmonds, PhD, associate professor in the department of epidemiology at the University of North Carolina Chapel Hill, told Healio.
“We wanted to rigorously examine the

Women who reported having health insurance were significantly more likely to initiate hepatitis C treatment vs. women without health insurance, according to a study published in Clinical Infectious Diseases.
“Direct-acting antivirals (DAAs) are highly effective at curing hepatitis C and recommended for most people. However, the high cost of these newer medications is a major barrier to access,” Andrew Edmonds, PhD, associate professor in the department of epidemiology at the University of North Carolina Chapel Hill, told Healio.
“We wanted to rigorously examine the